Xanthine Analogs Suppress <i>Trypanosoma cruzi</i> Infection In Vitro Using PDEs as Targets

<i>Trypanosoma cruzi</i> (<i>T. cruzi</i>), the causative agent of Chagas disease, has infected 6 million people, putting 70 million people at risk worldwide. Presently, very limited drugs are available, and these have severe side effects. Hence, there is an urgency to delve into other pathways and...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Amita R. Banga, Konjeti R. Sekhar, Kayla J. Rayford, Ashutosh Arun, Peace Odiase, Amar P. Garg, Maria F. Lima, Pius N. Nde, Fernando Villalta, Girish Rachakonda
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2022-09-01
Saila:	Microbiology Research
Gaiak:	cAMP cGMP phosphodiesterase (PDE) Chagas disease green fluorescent protein (GFP) <i>Trypanosoma cruzi</i> strains
Sarrera elektronikoa:	https://www.mdpi.com/2036-7481/13/4/52
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!